Institute of Clinical Pharmacology, Anhui Medical University, Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Anhui Collaborative Innovation Center of Anti-Inflammatory and Immune Medicine, Hefei, China.
Department of Gynecology, The First Affiliated Hospital of Shenzhen University, Health Science Center, Shenzhen Second People's Hospital, Shenzhen, China.
Front Immunol. 2021 Jun 17;12:655477. doi: 10.3389/fimmu.2021.655477. eCollection 2021.
Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease. Joint inflammation of RA is closely related to infiltration of immune cells, synovium hyperplasia, and superfluous secretion of proinflammatory cytokines, which lead to cartilage degradation and bone erosion. The joint synovium of RA patients contains a variety of immune cellular types, among which monocytes/macrophages and T cells are two essential cellular components. Monocytes/macrophages can recruit and promote the differentiation of T cells into inflammatory phenotypes in RA synovium. Similarly, different subtypes of T cells can recruit monocytes/macrophages and promote osteoblast differentiation and production of inflammatory cytokines. In this review, we will discuss how T cell-monocyte/macrophage interactions promote the development of RA, which will provide new perspectives on RA pathogenesis and the development of targeted therapy.
类风湿关节炎(RA)是一种慢性炎症性自身免疫病。RA 的关节炎症与免疫细胞浸润、滑膜增生和过多的促炎细胞因子分泌密切相关,导致软骨降解和骨质侵蚀。RA 患者的关节滑膜含有多种免疫细胞类型,其中单核细胞/巨噬细胞和 T 细胞是两个重要的细胞成分。单核细胞/巨噬细胞可以在 RA 滑膜中招募并促进 T 细胞向炎症表型分化。同样,不同亚型的 T 细胞可以招募单核细胞/巨噬细胞,并促进成骨细胞分化和炎症细胞因子的产生。在这篇综述中,我们将讨论 T 细胞-单核细胞/巨噬细胞相互作用如何促进 RA 的发展,这将为 RA 的发病机制和靶向治疗的发展提供新的视角。